Clinical Research Directory
Browse clinical research sites, groups, and studies.
FAP PET/CT for Staging Patients With Breast Cancer
Sponsor: Odense University Hospital
Summary
This study aims to evaluate the clinical utility of \[68Ga\]Ga-FAP-2268 PET/CT for disease staging and assessment in patients with high-risk primary breast cancer. By targeting fibroblast activation protein (FAP), this novel imaging approach may offer improved tumor visualization compared to conventional imaging, which may help improve treatment planning.
Official title: [⁶⁸Ga]Ga-FAP-2286 PET/CT for Staging and Restaging Patients With Newly Diagnosed Primary Breast Cancer: a Phase II Study (FAPILOUS)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
65
Start Date
2026-06-01
Completion Date
2029-01
Last Updated
2026-04-13
Healthy Volunteers
No
Conditions
Interventions
68Ga-FAP-2286
One scan at baseline staging, and for those reciving NACT : one scan before surgery.